Described herein are pharmaceutical packaging methods which avoid oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive prescription drugs, these kinds of programs together with a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely low permea